{
    "2020-08-20": [
        [
            {
                "time": "",
                "original_text": "股大宗交易超千万元 智飞生物交易额最高",
                "features": {
                    "keywords": [
                        "大宗交易",
                        "智飞生物"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物今日出现11笔共计4.55亿元折价大宗交易",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "大宗交易",
                        "折价"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：新冠病毒疫苗正处于Ⅰ、Ⅱ期临床试验过程中",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新冠病毒疫苗",
                        "临床试验"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本合伙人解密：普通人何时才能打上新冠疫苗",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "新冠疫苗"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}